Biomind Labs IncCBOE Canada:BMNDView on OTC Pink - Current Information
- LAST PRICE0.3100
- TODAY'S CHANGE (%)-0.2800 (-47.4576%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.5700 / 0.5900
- Day Range
- 52 Week Range
- Volume1,500
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMND |
|---|---|---|
| 11:20 ET | 1500 | 0.31 |
| 04:00 ET | 1500 | 0.31 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biomind Labs Inc | 24.0M | -23.6x | --- |
Helix BioPharma Corp | 34.3M | -3.6x | --- |
Thiogenesis Therapeutics Corp | 30.9M | -7.0x | --- |
Sona Nanotech Inc | 29.0M | -8.4x | --- |
Defence Therapeutics Inc | 24.5M | -2.0x | --- |
KDA Group Inc | 43.0M | -90.1x | --- |
Company Information
Biomind Labs Inc. is a biotech research and development company. It is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of key endogenous substances which are occurring in the human body and an organic compound that includes many neurotransmitters for treating a range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, it is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.
Contact Information
- Headquarters
- 181 Bay Street , Suite 1800, Brookfield PlaceTORONTO, ON, Canada M5J 2T9
- Phone
- 800-439-5136
- Fax
- ---
Executives
- Chairman of the Board
- Ravi Sood
- Chief Executive Officer, Director
- Alejandro Antalich
- Chief Financial Officer, Director
- Oscar Leon
- Chief Scientific Officer
- Paola Dellavalle
- Chief Legal Officer
- Juan Presa
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 77.5M |
Biomind Labs Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.01 |
Book Value | $-0.03 |
P/E Ratio | -23.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
